Results 181 to 190 of about 2,207,082 (265)
How is health equity considered in policy evaluations employing quasi-experimental methods? A scoping review and content analysis. [PDF]
Eur J Public HealthSell K, Rabbani S, Burns J.
europepmc +1 more source
Biofuels, Bioproducts and Biorefining, EarlyView.Abstract Hydrogen is increasingly recognized as a crucial element in a sustainable future, providing a variety of solutions to address the climate crisis. Its importance is emphasized by its adaptability, high energy content, and capacity to decarbonize a number of industries, including steel production, the chemical sector (e.g., ammonia and methanol ...
Mine Güngörmüşler +2 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims The incidence of postmenopausal bleeding (PMB) has been increasing over the past years. Little is known about the risk of PMB after COVID‐19 vaccination. Our study aimed to investigate this based on routine general practitioner (GP) healthcare data from the Netherlands.
Rana Jajou +5 more
wiley +1 more source
Analysis of government subsidy strategies in the supply chain of science and technology innovation platform. [PDF]
PLoS OneZhang G, Chen C, Xie J, Hu Q.
europepmc +1 more source
Institutional Economics of Public Firms and Administrations [PDF]
, 1994 Picot, Arnold, Wolff, Birgitta
core
British Journal of Clinical Pharmacology, EarlyView.Aims The aim of this study was to create a Turkish version of the Ascertaining Barriers to Compliance (ABC) taxonomy for medication adherence. Methods A systematic literature search was conducted, followed by a national Delphi study using suggested methods of the International Society for Medication Adherence for translation of the ABC taxonomy for ...
Cansu Goncuoglu +5 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt +7 more
wiley +1 more source
The role of the right valuation method in setting the firm's break-even price for mpox (and other) vaccines. [PDF]
BMJ Glob HealthEngelen PJ, Cassimon D.
europepmc +1 more source